Who is sponsoring NCT02075632?

NCT02075632 is sponsored by GlaxoSmithKline.

What condition does NCT02075632 study?

NCT02075632 studies Eczema, Allergy Symptoms, Psoriasis, Itch.

What drugs are being tested in NCT02075632?

Interventions: Alclometasone dipropionate cream.

What is the status of NCT02075632?

NCT02075632 is currently COMPLETED.

Last reviewed 2014-08-28 · How we verify

A Mult-Center, Open-Label Study to Evaluate Product Duration of Use Experience With Aclometasone Diproprionate Cream

NCT02075632 Phase 2 COMPLETED Results posted

This is a multi-center, open-label study to evaluate whether participants follow the duration of use instructions for short-term use of alclometasone dipropionate in a population of participants with itchy skin conditions who would use OTC treatments for relief. The study population will be composed of two different cohorts: chronic condition sufferers (eczema or psoriasis) and participants who suffer from occasional itchy skin experiences (such as poison ivy, oak, sumac, insect bites, or skin irritations due to jewelry, cosmetics, detergents, or soaps) where an anti-itch medication would be used.

Details

Lead sponsor	GlaxoSmithKline
Phase	Phase 2
Status	COMPLETED
Enrolment	310
Start date	2006-09
Completion	2006-11

Conditions

Eczema
Allergy Symptoms
Psoriasis
Itch

Interventions

Alclometasone dipropionate cream

Primary outcomes

Number of Participants With Incorrect Duration of Use of the Medication — Day1-Day 14
Incorrect duration of use was defined as the use of study medication for more than 7 consecutive days and/or more than three times in a day. Participants were asked the reasons of doing so and they were allowed to select multiple reasons also, if applicable.